Context Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	54.53	66	94.43	14.45	35.5	49.64
Cash & Short-Term Investments	54.53	66	94.43	14.45	35.5	49.64
Cash Growth	-38.97%	-30.11%	553.50%	-59.29%	-28.48%	16976.13%
Other Current Assets	3.99	2.36	3.47	1.6	2.36	1.62
Total Current Assets	58.52	68.35	97.9	16.05	37.85	51.26
Net Property, Plant & Equipment	0.34	0.14	0.23	0.02	0.08	-
Other Long-Term Assets	-	-	-	-	0.03	0.05
Total Assets	58.86	68.49	98.13	16.06	37.97	51.31
Accounts Payable	2.47	2.53	1.45	2.38	0.94	1.83
Accrued Expenses	3.91	5.38	1.19	1.81	2.22	1.21
Current Portion of Leases	0.16	0.11	0.11	-	0.06	-
Total Current Liabilities	6.53	8.02	2.75	4.19	3.21	3.03
Long-Term Leases	0.12	-	0.11	-	-	-
Total Long-Term Liabilities	0.12	-	0.11	-	-	-
Total Liabilities	6.66	8.02	2.86	4.19	3.21	3.03
Common Stock	0.09	0.09	0.09	0.02	0.02	0.02
Additional Paid-in Capital	191.69	191.29	189.96	79.91	78.83	77.51
Retained Earnings	-139.58	-130.9	-94.78	-68.05	-44.09	-29.25
Total Common Shareholders' Equity	52.2	60.47	95.27	11.87	34.76	48.27
Shareholders' Equity	52.2	60.47	95.27	11.87	34.76	48.27
Total Liabilities & Equity	58.86	68.49	98.13	16.06	37.97	51.31
Total Debt	0.28	0.11	0.22	0	0.06	0
Net Cash (Debt)	54.25	65.88	94.21	14.45	35.44	49.64
Net Cash Growth	-17.66%	-30.07%	551.98%	-59.23%	-28.59%	-
Net Cash Per Share	0.57	0.69	1.61	0.91	2.22	17.52
Book Value	52.2	60.47	95.27	11.87	34.76	48.27
Book Value Per Share	0.55	0.64	1.63	0.74	2.18	17.04
Tangible Book Value	52.2	60.47	95.27	11.87	34.76	48.27
Tangible Book Value Per Share	0.55	0.64	1.63	0.74	2.18	17.04

SEC Filings: 10-K · 10-Q